Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Feb 2026 for Syndax Pharmaceuticals Inc. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Dennis Podlesak: trading record in brief
All filings by Dennis Podlesak on record concern Syndax Pharmaceuticals Inc, in the capacity of board member. The record holds 8 filings, for trades running from 5 October 2021 to 4 February 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 6 February 2026, reports a share grant in Syndax Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Dennis Podlesak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
48,000 shares0Common StockSEC:0001193125-26-041200:0
19,200 shares@ US$7.2021.9% of flowCommon StockSEC:0000950170-25-109815:0
50,000 shares0Common StockSEC:0000950170-25-016380:0
34,000 shares0Common StockSEC:0001562180-24-001215:0
32,000 shares0Common StockSEC:0001562180-23-000947:0
66,840 shares@ US$6.32100.0% of flowCommon StockSEC:0001562180-22-006705:0
32,000 shares0Common StockSEC:0001562180-22-001076:0
463 shares0Common StockSEC:0001562180-21-006357:0
8 of 8 declarations
